CytoCore has entered into a four year agreement with HT Hospital Technologies, a subsidiary of MOSS, for distribution of the SoftPAP Cervical Cell Collector into Switzerland.
Subscribe to our email newsletter
HT Hospital Technologies agreement calls for minimum sales of 150,000 units the first year, 200,000 units the second, and 250,000 units the third year.
Robert McCullough, CEO of CytoCore, said: “Franco Pappa, president of MOSS continues to demonstrate his support and enthusiasm for the SoftPAP Collector by expanding his distribution territory from Italy to include Switzerland as well. We expect to receive an initial order to ship first SoftPAP products to Switzerland by mid-April.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.